Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 18Thoracic 2Sarcoma 2Gastrointestinal 2Tumor-Agnostic 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Sarcoma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Ovarian Neoplasms 1Lung Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1

Interventions

Magnetic Resonance Spectroscopy 13Ifosfamide 12Doxorubicin 12Blood Specimen Collection 12Radiotherapy 11Methotrexate 10fludarabine phosphate 9Surgical Procedures, Operative 9Radiosurgery 9Cyclophosphamide 9Surveys and Questionnaires 8Cyclosporine 8Proton Therapy 7Peripheral Blood Stem Cell Transplantation 7Busulfan 7Mycophenolic Acid 6Melphalan 6Whole-Body Irradiation 5Standard of Care 5Filgrastim 5Etoposide 5Early Intervention, Educational 5Carboplatin 5Biopsy 5Antilymphocyte Serum 5Vincristine 4Temozolomide 4Sunitinib 4Radiation Dose Hypofractionation 4Mesna 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Trastuzumab × Sarcoma × Clear all
NCT00847366 2018-03-15

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

AEterna Zentaris

Phase NA Completed
10 enrolled
BreastSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Sarcoma

NCT00433407 2012-10-04

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Jonsson Comprehensive Cancer Center

Phase NA Completed
12 enrolled
BreastGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Breast Neoplasms, Male, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡